Cormorant Asset Management’s Immuneering IMRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-3,295,273
| Closed | -$9.52M | – | 57 |
|
|
2024
Q1 | $9.52M | Sell |
3,295,273
-909,091
| -22% | -$2.63M | 0.42% | 44 |
|
|
2023
Q4 | $30.9M | Hold |
4,204,364
| – | – | 1.48% | 20 |
|
|
2023
Q3 | $32.3M | Hold |
4,204,364
| – | – | 1.88% | 15 |
|
|
2023
Q2 | $42.6M | Buy |
4,204,364
+1,818,183
| +76% | +$18.4M | 2.39% | 7 |
|
|
2023
Q1 | $23.2M | Buy |
2,386,181
+100,000
| +4% | +$971K | 1.53% | 17 |
|
|
2022
Q4 | $11.1M | Hold |
2,286,181
| – | – | 0.74% | 35 |
|
|
2022
Q3 | $32.7M | Hold |
2,286,181
| – | – | 2.29% | 15 |
|
|
2022
Q2 | $12.4M | Sell |
2,286,181
-16,445
| -0.7% | -$89K | 0.94% | 34 |
|
|
2022
Q1 | $14.9M | Hold |
2,302,626
| – | – | 1.14% | 25 |
|
|
2021
Q4 | $37.2M | Buy |
2,302,626
+50,000
| +2% | +$808K | 2.21% | 13 |
|
|
2021
Q3 | $58.5M | Buy |
+2,252,626
| New | +$58.5M | 2.38% | 11 |
|